Clinical Trials on Advanced Gastroenteropancreatic Neuroendocrine Tumor in Denmark

Total 136 results

Ipsen

Completed

To Evaluate the Optimal Dose of 68Ga-OPS202 as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)

Gastro-Enteropancreatic Neuroendocrine Tumor

United States, Austria, Denmark
Ipsen

Completed

Study For Evaluating The Value Of A Multi Biomarker Approach In Metastatic GEP NETs (EXPLAIN)

Gastroenteropancreatic Neuroendocrine Tumors

Finland, Norway, Sweden, Denmark, Latvia, Lithuania, Estonia
University of Aarhus
Novartis; The Danish Medical Research Council

Completed

Gastrointestinal Motility in Patients With Neuroendocrine Tumors

Neuroendocrine Tumor

Denmark
Herlev Hospital

Completed

Dendritic Cell Based Therapy of Malignant Melanoma

Advanced Melanoma

Denmark
Debiopharm International SA

Active, not recruiting

A Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Debio 4126 in Participants With Acromegaly or Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) (OXTEND-01)

Acromegaly | GEP-NET

United Kingdom, France, Spain, Italy, Poland, Denmark, Germany, Israel
Ipsen

Completed

Somatuline Autogel Preference and Health Economy Study (SAPHE)

Neuroendocrine Tumour With Carcinoid Symptoms

Denmark, Norway, Sweden
Herlev Hospital

Completed

App Teaches Doctors to Diagnose Skin Cancer

Carcinoma | Melanoma (Skin)

Denmark
Rigshospitalet, Denmark

Enrolling by invitation

Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms

Neuroendocrine Tumors | Neuroendocrine Carcinoma | Neuroendocrine Carcinoma Metastatic | GEP-NET

Denmark
Herlev Hospital
GENIS

Terminated

Pharmacokinetic Profile of T-ChOS™ in Subjects With Advanced Solid Tumors (CHITIN) (CHITIN)

Advanced Solid Tumors

Denmark
MonTa Biosciences ApS
Allucent

Recruiting

Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours

Advanced Solid Tumor

Belgium, Denmark, Spain
Tine Gregersen, MD

Recruiting

Dosimetry Based PRRT Versus Standard Dose PRRT With Lu-177-DOTATOC in NEN Patients (DOBATOC)

Neuroendocrine Neoplasm

Denmark
AstraZeneca

Completed

Phase 1 Study of the Effect of Ketoconazole on the PK of Multiple Doses of Cediranib in Patients With Solid Tumours

Advanced Solid Tumors

Denmark, Canada
Rigshospitalet, Denmark

Enrolling by invitation

Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients

Sarcoma | Lymphoma | Breast Cancer | Neuroendocrine Tumors | Neuroendocrine Carcinoma | Neuroendocrine Carcinoma Metastatic

Denmark
University of Aarhus

Unknown

Fatigue and Quality of Life in Patients With Neuroendocrine Neoplasia

Neuroendocrine Tumors (NET) Health Related Qualito of Life (HRQoL)

Denmark
University of Aarhus
Aarhus University Hospital; Central Denmark Region

Recruiting

Perioperative Treatment With Tranexamic Acid in Melanoma (PRIME)

Melanoma

Denmark
Rigshospitalet, Denmark

Completed

PET/CT Imaging of Angiogenesis in Patients With Neuroendocrine Tumors Using 68Ga-NODAGA-E[c(RGDyK)]2

Neuroendocrine Tumors

Denmark
Rigshospitalet, Denmark

Completed

PET/CT Imaging of uPAR-expression in Patients With Neuroendocrine Tumors Using 68Ga-NOTA-AE105

Neuroendocrine Tumors

Denmark
Philogen S.p.A.
Immatics Biotechnologies GmbH

Terminated

F16IL2 Plus Paclitaxel in Metastatic Merkel Cell Carcinoma

Merkel Cell Carcinoma

Germany, Austria, Denmark, France, Spain, United Kingdom
Rigshospitalet, Denmark

Unknown

Phase I Trial: 68Ga-NODAGA-E(c[RGDyK])2 Positron Emission Tomography for Imaging Angiogenesis in Primary and Metastatic Tumor Lesions in Humans

Breast Cancer | Ovarian Cancer | Neuroendocrine Carcinoma

Denmark
Inge Marie Svane

Completed

T-cell Based Immunotherapy for of Melanoma

Melanoma

Denmark
Repare Therapeutics
Roche Pharma AG

Active, not recruiting

Study of RP-3500, Camonsertib, in Advanced Solid Tumors

Advanced Solid Tumor

United States, Canada, Denmark, United Kingdom
CDR-Life AG

Not yet recruiting

First in Human Study of CDR404 in HLA-A*02:01 Participants With MAGE-A4 Expressing Solid Tumors

Select Advanced Solid Tumors

United States, Denmark
Repare Therapeutics
Debiopharm International SA

Recruiting

Study of RP-6306 Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors (MYTHIC)

Advanced Solid Tumor

United States, Canada, Denmark
Morten Mau-Soerensen
Hospices Civils de Lyon; Gustave Roussy, Cancer Campus, Grand Paris; Institut... and other collaborators

Unknown

Selinexor in Patients With Advanced Thymoma and Thymic Carcinoma (TET-SEL)

Thymoma | Advanced Thymic Epithelial Tumour

Denmark, France
Aalborg University Hospital
Aarhus University Hospital

Completed

Perioperative Examination of Inflammatory Markers in Relation to Sentinel Lymph Node Biopsy in Patients With Melanoma; a Pilot Study

Melanoma | Surgery

Denmark
Aarhus University Hospital

Completed

Co-stimulatory Markers and Vitamin D Status in Anti-PD1 Treated Melanoma Patients

Malignant Melanoma

Denmark
Rigshospitalet, Denmark

Completed

Sentinel Node With Ultrasound Contrast in Melanoma

Malignant Melanoma

Denmark
Inge Marie Svane

Recruiting

Combination Therapy With Nivolumab and PD-L1/IDO Peptide Vaccine to Patients With Metastatic Melanoma

Metastatic Melanoma

Denmark
Odense University Hospital
Rigshospitalet, Denmark; Danish Cancer Society; REHPA, The Danish Knowledge Centre...

Completed

The Use of PatientReportedOutcomes (PRO)- CTCAE by Melanoma Patients Receiving Immunotherapy

Adverse Effects

Denmark
Herlev and Gentofte Hospital
Danish Cancer Society

Recruiting

The MELAcare Study: A New Method for Surveillance of Melanoma Patients

Cutaneous Melanoma

Denmark
Inge Marie Svane
Technical University of Denmark

Recruiting

ImmPACT Expanded Multiple Antigen Specific Endogenously Derived T Cells (MASE-T) to Patients With Metastatic Melanoma

Malignant Melanoma

Denmark
University of Aarhus
Aarhus University Hospital

Completed

Circulating Tumor Cells and Tumor DNA in HCC and NET

Carcinoma, Hepatocellular | Neuroendocrine Tumors

Denmark
Herlev Hospital

Enrolling by invitation

Dermoscopy Augmented Histology Trial, Consensus Agreement Diagnosis Made by Dermatopathology Experts

Melanoma (Skin) | Pigmented Lesions

Denmark
Inge Marie Svane
Copenhagen University Hospital at Herlev

Terminated

Peptide Vaccine and Temozolomide for Metastatic Melanoma Patients

Malignant Melanoma

Denmark
Inge Marie Svane

Completed

Peginterferon and TIL Therapy for Metastatic Melanoma

Metastatic Melanoma

Denmark
Inge Marie Svane

Completed

Vemurafenib and TIL Therapy for Metastatic Melanoma

Metastatic Melanoma

Denmark
Rigshospitalet, Denmark

Unknown

The Value of Preoperative Dynamic Lymphscintigraphy and Ultrasoundscanning, Eventually With FNA, for Identification of Malignant Sentinel Node(s) in Patients With Melanoma

Melanoma

Denmark
Rigshospitalet, Denmark

Recruiting

uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the Lung

Non-small Cell Lung Cancer | Malignant Pleural Mesothelioma | Large Cell Neuroendocrine Carcinoma of the Lung

Denmark
European Organisation for Research and Treatment...

Terminated

Vaccine Therapy in Treating Patients With Melanoma of the Eye

Intraocular Melanoma

Belgium, Denmark
The Netherlands Cancer Institute
Copenhagen University Hospital at Herlev

Active, not recruiting

Study Comparing TIL to Standard Ipilimumab in Patients With Metastatic Melanoma (TIL)

Metastatic Melanoma

Netherlands, Denmark
Rigshospitalet, Denmark

Completed

MicroRNA Expression and Function in Cutaneous Malignant Melanoma

Melanoma

Denmark
Onxeo

Terminated

Safety and Efficacy Study of Electrotransfer of Plasmid AMEP to Treat Advanced or Metastatic Melanoma (AMEP)

Melanoma

Slovenia, Denmark, France
Herlev Hospital

Completed

Vaccination With Peptides in Combination With Either Ipilimumab or Vemurafenib for the Treatment of Unresectable Stage III or IV Malignant Melanoma

Malignant Melanoma With Metastasis

Denmark
Merck Sharp & Dohme LLC

Terminated

A Study of MK-1088 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-1088-002)

Advanced Solid Tumors

Canada, United States, Denmark, Israel, Switzerland
Incyte Corporation

Active, not recruiting

A Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced Malignancies

Advanced Solid Tumors

United States, Sweden, Netherlands, Norway, Denmark
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Completed

Phase 1 Trial of MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Combination With Radiotherapy

Advanced Solid Tumors

United States, Germany, Norway, Netherlands, Belgium, Denmark, Sweden, Switzerland
Ipsen

Completed

Efficacy and Safety Study in Pancreatic or Midgut Neuroendocrine Tumours Having Progressed Radiologically While Previously Treated With Lanreotide Autogel® 120 mg (CLARINET FORTE)

Midgut Neuroendocrine Tumours | Pancreatic Tumours

Spain, United Kingdom, Denmark, Belgium, Germany, France, Netherlands, Ireland, Italy, Poland
Herlev Hospital

Enrolling by invitation

AI Augmented Training for Skin Specialists (AISC-SS)

Melanoma | Skin Cancer

Denmark
Herlev Hospital

Enrolling by invitation

Safety and Avoidance of Futile Excisions Through Skin Tele-triage (SAFEST)

Telemedicine | Melanoma (Skin)

Denmark
Ipsen

Active, not recruiting

A Long-term Safety Surveillance Study in Participants Previously Treated With 177Lu-IPN01072

Neuroendocrine Tumors

Austria, Denmark, Switzerland, Australia, United Kingdom, France

Clinical Trials on Advanced Gastroenteropancreatic Neuroendocrine Tumor in Denmark

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Equatorial Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations